Bladder Metastasis of Type 2 Papillary Renal Cell Carcinoma: A Case Report
DOI:
https://doi.org/10.24915/apuj.274Keywords:
Carcinoma, RenalCell/surgery, Metastasectomy, Neoplasm Metastasis, Urinary Bladder Neoplasms/secondaryAbstract
Rare cases of renal cell carcinoma bladder metastases have been reported, with clear-cell renal cell carcinoma subtype accounting for the majority of them. Bladder metastases of papillary renal cell carcinoma are limited to only a few case reports. We present the case of an 81-year-old woman who came to the emergency department complaining of hematuria and ultrasound evidence of a bladder mass. Two years earlier, she underwent a right nephrectomy due to papillary renal cell carcinoma. Histopathology revealed a metastatic bladder tumor of papillary renal cell carcinoma. Bladder metastases of papillary renal cell carcinoma are very rare. Metastasectomy can provide palliation of symptoms and improve survival in selected patients. Although there is scant information regarding systemic therapy in non-clear renal cell carcinoma, pazopanib may have a role.
Downloads
References
International Agency for Research on Cancer-World Health Organization. Global Cancer Observatory, Globocan 2020 [accessed 20 December 2025] Available at: https://gco.iarc.fr/today/data/factsheets/cancers/29-Kidney-factsheet.pdf.
Matsumoto K, Hayakawa N, Nakamura S, Oya M. Bladder metastasis from renal cell carcinoma: retrospective analysis of 65 reported cases. Clin Exp Metastasis. 2015;32:135-41. doi:10.1007/s10585-015-9698-1
Gajasinghe DG, Nazeer I, Maddumage HP, Perera C, Abeygunasekera AM. Metachronous bladder metastases of a type 2 papillary renal cell carcinoma: a case report and review of the literature. World J Surg Oncol. 2016;14:219. doi:10.1186/s12957-016-0986-2
Saitoh H. Distant metastasis of renal adenocarcinoma. Cancer. 1981;48:1487-91. doi:10.1002/1097-0142(19810915)48:6<1487::aid-cncr2820480635>3.0.co;2-9
Capitainio U, Bensalah K, Bex A, Boorjian SA, Bray F, Coleman J, et al. Epidemiology of renal cell carcinoma. Eur Urol. 2019;75:74-84. doi:10.1016/j.eururo.2018.08.0362019
Ljungberg B, Campbell SC, Choi HY, Jacqmin D, Lee JE, Weikert S, et al. The epidemiology of renal cell carcinoma. Eur Urol. 2011;60:615-21. doi:10.1016/j.eururo.2011.06.049. Erratum in: Eur Urol. 2011;60:1317.
Gajasinghe DG, Nazeer I, Maddumage HP, Perera C, Abeygunasekera AM. Metachronous bladder metastases of a type 2 papillary renal cell carcinoma: a case report and review of the literature. World J Surg Oncol. 2016;14:219. doi:10.1186/s12957-016-0986-2
Kavoliws JP, Mastorakos DP, Pavlovich C, Russo P, Burt ME, Brady MS. Resection of metastatic renal cell carcinoma. J Clin Oncol. 1998;16:2261-6. doi:10.1200/JCO.1998.16.6.2261
Hsieh PY, Hung SC, Li JR, Wang SS, Yang CK, Chen CS, et al. The effect of metastasectomy on overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis. Urol Oncol. 2021;39:422-30. doi:10.1016/j.urolonc.2021.02.026
Yiu W, Chen J, Zhao B, Zhang W, Chen L, Liu H. The Efficacy of Adjuvant Targeted Therapy in Patients with Advanced Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Comput Math Methods Med. 2022;2022:7341294. doi:10.1155/2022/7341294
Chahoud J, Msaouel P, Campbell MT, Bathala T, Xiao L, Gao J, et al. Nivolumab for the Treatment of Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC): A Single-Institutional Experience and Literature Meta-Analysis. Oncologist. 2020;25:252-8. doi:10.1634/theoncologist.2019-0372
Downloads
Published
Issue
Section
License
Copyright (c) 2023 APU Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
